Name: Pakistan approves Chinese Sinopharm COVID-19 vaccine for emergency use
Brand: reuters.com
SKU: reuters-com-3776
Availability: OnlineOnly

critic

Pakistan approves Chinese Sinopharm COVID-19 vaccine for emergency use

preview

By ISLAMABAD (Reuters) - Pakistan on Monday approved the Chinese Sinopharm COVID-19 vaccine for emergency use, a government statement said, two days after AstraZeneca’s vaccine developed with Oxford University received a similar authorization.The Drug Regulatory Authority Pakistan (DRAP) said the vaccine, manufactured by China National Pharmaceutical Group (SinoPharm), had been given emergency use approval (EUA).Pakistan’s health ministry has said the country was in process of speaking to different vaccine makers.“The two COVID-19 vaccines have been granted EUA with certain conditions,” a DRAP’s spokesman said, adding that both vaccines have been evaluated for their safety and quality.The authorization will be reviewed on quarterly basis for further data regarding safety, efficacy and quality, the spokesman said.Pakistan has been engaging with a number of vaccine makers, health minister Faisal Sultan said over the weekend, adding that the country could get “in the range of tens of millions” of vaccine doses under an agreement with China’s Cansino Biologics Inc.The vaccine company’s Ad5-nCoV COVID-19 candidate is nearing completion of Phase III clinical trials in Pakistan. The preliminary results of the Cansino vaccine may come in by mid-February, Sultan said.However, Pakistan has yet to place an order to procure any vaccine.The minister said Pakistan planned to cover vaccines for the majority of the population for free, adding that private companies could also be allowed to import and sell vaccines once supply was available to an authorized company.Pakistan reported 1,920 new coronavirus infections and 46 deaths on Monday, taking the total number of cases to more than 521,212 with fatalities approaching 11,000.Reporting by Asif Shahzad; Editing by Alex Richardson and Bill BerkrotOur Standards:

By ISLAMABAD (Reuters) - Pakistan on Monday approved the Chinese Sinopharm COVID-19 vaccine for emergency use, a government statement said, two days after AstraZeneca’s vaccine developed with Oxford University received a similar authorization.The Drug Regulatory Authority Pakistan (DRAP) said the vaccine, manufactured by China National Pharmaceutical Group (SinoPharm), had been given emergency use approval (EUA).Pakistan’s health ministry has said the country was in process of speaking to different vaccine makers.“The two COVID-19 vaccines have been granted EUA with certain conditions,” a...

public

Asif Shahzad

Top and breaking news, pictures and videos from Reuters. For more breaking business news, follow @ReutersBiz.

reuters.com

Credible

Speculation

Anecdotal Evidence

Generalization

Stacking the Deck

Appeal to Authority

Straw Man

Slippery Slope

Emotional Appeal

Red Herring

False Dilemma

Illogical

Moral Equivalency

Ad Hominem

Correlation w/o Causation

Semantics

Begging the Question

Faulty Analogy

Non Sequitur

Bandwagon

Dogmatism

Failing Occam's Razor

Biased

Pure Opinion

Hit Piece

Racial Bias

National Bias

Religious Bias

Financial Incentive

Political Agenda

Gender Bias

Misused Image/Video

Study Misinterpreted

Mistake

Misused Term

Science Misrepresented

Factual Error

Satire

Surface Level

Lack of Reliable Sources

Sensational

Not Credible

Investigative

Balanced

Well Sourced

Great Context

sports

entertainment

U.S.

international

business

technology

science

culture

politics

media

health

Pakistan approves Chinese Sinopharm COVID-19 vaccine for emergency use

No article scores yet.

CRITIC REVIEWS

PUBLIC REVIEWS